Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome

References

• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–2438.
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Key TJ, Kahsar- Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.
   PubMed Web of Science ®Google Scholar
• Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:999–1004.
   PubMed Web of Science ®Google Scholar
• Ehrmann D, Liljenquist D, Kasza K, Azziz R, Legro R, Ghazzi M, for the PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;91:48–53.
   PubMed Web of Science ®Google Scholar
• Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, Guzick DS, Hoeger KM. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4780–4786.
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 2001;16:1255–1260.
   PubMed Web of Science ®Google Scholar
• Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endo J 2001;141:649–656.
   Google Scholar
• Rosebaum M, Leibel RL. Role of gonadal steroids in the sexual dismorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab 1999;84:1784–1789.
   PubMed Web of Science ®Google Scholar
• Acién P, Quereda F, Matallin P. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogenous group of disorders. Fertil Steril 1999;71:32–40.
   Google Scholar
• Barber TM, McCarthy MI, Waset JAH, Frank KS. Obesity and polycystic ovary syndrome. Clin Endocrinol 2006;65:137–145.
   PubMed Web of Science ®Google Scholar
• Rouzi AA, Ardawi MM. Insulin resistance in women with polycystic ovary syndrome contributed to cardiovascular disease risk factors independent of obesity. Fertil Steril 2001;76:296–299.
   Web of Science ®Google Scholar
• Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrinol Rev 2000;21:697–738.
   PubMed Web of Science ®Google Scholar
• Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002;282:E1023–E1028.
   PubMed Web of Science ®Google Scholar
• Sjostrom CD, Hakangard AC, Lissner L, Sjostrom L. Body compartment and subcutaneous adipose tissue distribution—risk factor patterns in obese subjects. Obes Res 1995;3:9–22.
   PubMedGoogle Scholar
• Garcia AL, Wagner K, Hothorn T, Koebnick C, Zunft HJF, Trippo U. Improved prediction of body fat by measuring skinfold thickness, circumferences, and bone breadths. Obes Res 2005;13:626–634.
   PubMedGoogle Scholar
• Seidell JC, Perusse L, Despres J-P, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001;74:315–321.
   PubMed Web of Science ®Google Scholar
• Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003;107:1626–1631.
   PubMed Web of Science ®Google Scholar
• Tankó LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C, Larsen PJ. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 2004;110:2246–2252.
   PubMed Web of Science ®Google Scholar
• Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CDA, Yudkin JS, Heine RJ, Nujpels G, Seidell JC. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn Study. Diabetes Care 2004;27:372–377.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Adams-Huet B, Vega GL. Variable contribution of fat content and distribution to metabolic syndrome risk factors. Metab Syndr Relat Disod 2008;6:281–288.
   PubMedGoogle Scholar
• Maitra A, Pingle RR, Menon PS, Naik V, Gokral JS, Meherji PK. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women. Int J Fertil Women Med 2001;46:271–277.
   PubMedGoogle Scholar
• Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:428–432.
   PubMed Web of Science ®Google Scholar
• Tankó LB, Bruun JM, Alexandersen P, Bager YZ, Richelsen B, Christiansen C, Larsen PJ. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity implications for atherogenesis. Circulation 2004;110:2246–2252.
   PubMed Web of Science ®Google Scholar
• Tafeit E, Möller R, Rackl S, Giulian A, Urdl W, Freytag U, Crailsheim K, Horejsi SR. Subcutaneous adipose tissue pattern in lean and obese women with polycystic ovary syndrome. Exp Biol Med 2003;228:710–716.
   Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 2001;16:1255–1260.
   PubMed Web of Science ®Google Scholar
• Tousignant B, Faraj M, Conus F, Garrel D, Brochu M, Rabasa-Lhoret R, Coderre L. Body fat distribution modulates insulin sensivity in post-menopausal and obese women: a MONET study. Int J Obes 2008;32:1626–1632.
   Web of Science ®Google Scholar
• Lee K, Lee S, Kim YJ. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008;24:625–631.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91:4237–4245.
   PubMed Web of Science ®Google Scholar
• Wallace AM, Sattar N. The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. Clin Biochem Rev 2007;28:79–92.
   PubMedGoogle Scholar
• Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPARγ. PPAR Res 2007;1–23. DOI:10.1155/2007/49109.
   Web of Science ®Google Scholar
• Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA. Steroidogenic alterations and androgen excess in PCOS. Steroids 2006;771:751–759.
   Google Scholar
• Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M. Disruption of the joint synchrony of Luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:72–79.
   PubMed Web of Science ®Google Scholar
• Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: increased peripheral 5αredutase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2760–2766.
   PubMed Web of Science ®Google Scholar
• Barber TM, Wass JA, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol 2007;66:513–517.
   PubMed Web of Science ®Google Scholar
• Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Eur J Endocrinol 2008;158:861–865.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrom V, Flyvberg A, Hermann AP. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and control. Eur J Endocrinol 2006;155:337–345.
   PubMed Web of Science ®Google Scholar
• Wake DJ, Strand M, Rask E, Westerbacka J, Lvingstone DEW, Sodeberg S, Andrew R, Yki-Jarvinen H, Olsson T, Walker BR. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol 2007;66:440–446.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Toth MJ, Pohelman ET. Sex hormone-binding globulin levels in middle-aged premenopausal women-associations with visceral obesity metabolic profile. Diabetes Care 1999;22:1875–1881.
   PubMed Web of Science ®Google Scholar